drugs major Roche has a 22-per cent increase in sales
to $6 billion in the first quarter ended March 31, boosted
by global demand for flu drug Tamiflu.
of Tamiflu, being stockpiled by several countries as a
precaution against any possible outbreak of bird flu,
rose 37 per cent over the first quarter of last year with
predictions of annual sales of Tamiflu reaching close
to the billion-dollar mark in 2006.
cancer drugs, of which it is the leading global maker
rose by 52 per cent year-on-year, led by demand for Avastin,
effective in the treatment of colon, breast and lung cancers.
December 2005 the New England Journal of Medicine,
had suggested that the drug could become ineffective as
the virus could develop more quickly than expected.